Gemma Currie

Dr. Gemma Currie is an Honorary Clinical Senior Lecturer at the University of Glasgow's School of Cardiovascular & Metabolic Health. Her research focuses on vascular biology, diabetes-related complications, and hypertension, with a particular emphasis on proteomics, biomarkers, and clinical trials. She collaborates extensively on studies like the PRIORITY trial, investigating early detection of diabetic kidney disease and interventions to delay progression. Her work also addresses gender differences in cardiovascular health, including transgender health and vascular aging mechanisms. Key areas of interest include endothelial dysfunction, biomarker discovery, and translational medicine in chronic diseases.

Dr. Currie’s research spans clinical and basic science, with contributions to understanding the role of proteomics in renal disease, hypertension management strategies, and vascular pathophysiology. She frequently collaborates with experts like Christian Delles and Rhian Touyz, co-authoring studies on topics ranging from mineralocorticoid receptor antagonism to preeclampsia pathways. Her work integrates clinical trials, epidemiological analyses, and biomarker validation to improve patient outcomes in cardiovascular and metabolic disorders.

Her recent studies highlight advancements in risk stratification for kidney and cardiovascular events in diabetes, as well as the impact of gender-affirming hormone therapy on vascular health. While no specific awards are listed, her prolific publication record reflects sustained contributions to cardiovascular and renal medicine.